Geoffrey Kelly
0009-0003-2991-2425
1 paper found
Refreshing results…
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Missing publications? Search for publications with a matching author name.